Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer

Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping

(2022) Cassandra White et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma

(2022) Satoru Matsuda et al.   ANNALS OF SURGERY

Bifunctional effect of the inflammatory cytokine tumor necrosis factor α on megakaryopoiesis and platelet production

(2022) Tiantian Chu et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy

(2021) Kazuma Fujita et al.   Esophagus

Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects

(2020) Jiaming Li et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy

(2020) Hisanaga Nomura et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Functional annotation of noncoding causal variants in autoimmune diseases

(2019) Ali Yousefian-Jazi et al.   GENOMICS

Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma

(2018) Yasuhiro Arakawa et al.   Oncology Letters

Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients

(2018) Sander Bins et al.   CLINICAL PHARMACOKINETICS

The role of pharmacogenetics in capecitabine efficacy and toxicity

(2016) S.W. Lam et al.   CANCER TREATMENT REVIEWS

IL-6 and MCP-1 genetic polymorphisms are predictive of decreased platelet counts caused by chemoradiotherapy in esophageal cancer

(2016) Kazuma Fujita et al.   Esophagus

Genetic Polymorphisms in SLC23A2 as Predictive Biomarkers of Severe Acute Toxicities after Treatment with a Definitive 5-Fluorouracil/Cisplatin-Based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma

(2014) Tetsuya Minegaki et al.   International Journal of Medical Sciences

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma

(2013) Hiroki Hara et al.   CANCER SCIENCE

Epidemiology of Esophageal Cancer in Japan and China

(2013) Yingsong Lin et al.   JOURNAL OF EPIDEMIOLOGY

Effects of 5-fluorouracil chemotherapy on fatigue: Role of MCP-1

(2012) S.E. Mahoney et al.   BRAIN BEHAVIOR AND IMMUNITY

Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin

(2012) TETSUYA MINEGAKI et al.   Oncology Letters

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

(2010) S Laechelt et al.   PHARMACOGENOMICS JOURNAL